Search

everythinglearnresearchcommunity

for

Search:↓

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Androgens may block hair growth signals, targeting this could treat hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Human keratinocytes do not naturally respond to androgens.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Testosterone may slow down wound healing and increase inflammation.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Suppressing certain hormones might help prevent prostate cancer.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Minoxidil can reduce functions related to androgen receptors.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Saw palmetto extracts might help treat male hair loss and need more research.